510(k) K092322

ELECSYS RUBELLA IGM IMMUNOASSAY by Roche Diagnostics — Product Code LFX

K092322 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "ELECSYS RUBELLA IGM IMMUNOASSAY". The FDA issued a decision of Substantially Equivalent on Mar 12, 2010. The device falls under product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Roche Diagnostics has 456 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 12, 2010
Date Received
Aug 4, 2009
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class
Class II
Regulation Number
866.3510
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K092322. Report a data issue: hello@regdatalab.com.